AstraZeneca CEO: If you manufacture locally, there's no need to increase prices

Astroenica beating second quarter revenue and profit expectations, citing robust sales of newer cancer, heart and kidney disease medicines. I did speak with the CEO about the quarter and he expected tariff impact on pricing weight loss drugs as well. I also asked about the company's recently announced $50 billion investment to expand manufacturing and research here in the US.Listen, the innovation in this country is tremendous. uh the US is leading uh the world in biioharmaceutical uh innovation and I think ...